osilodrostat (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

Cushing Disease

Pending FDA approval for treatment of endogenous Cushing syndrome

Next:

Pharmacology

Mechanism of Action

Orally administered steroidogenesis inhibitor of 11-beta-hydroxylase, an enzyme which catalyses the final step of cortisol synthesis in the adrenal cortex

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.